-
Cost of disorders of the brain in Europe 2010
October 2011 (Vol. 21 | No. 10 | Pages 718-779)
Anders Gustavsson, Mikael Svensson, Frank Jacobi, Christer Allgulander, Jordi Alonso, Ettore Beghi, Richard Dodel, Mattias Ekman, Carlo Faravelli, Laura Fratiglioni, Brenda Gannon, David Hilton Jones, Poul Jennum, Albena Jordanova, Linus Jönsson, Korinna Karampampa, Martin Knapp, Gisela Kobelt, Tobias Kurth, Roselind Lieb, Mattias Linde, Christina Ljungcrantz, Andreas Maercker, Beatrice Melin, Massimo Moscarelli, Amir Musayev, Fiona Norwood, Martin Preisig, Maura Pugliatti, Juergen Rehm, Luis Salvador-Carulla, Brigitte Schlehofer, Roland Simon, Hans-Christoph Steinhausen, Lars Jacob Stovner, Jean-Michel Vallat, Peter Van den Bergh, Jim van Os, Pieter Vos, Weili Xu, Hans-Ulrich Wittchen, Bengt Jönsson, Jes Olesen, on behalf of the CDBE2010 study group
-
Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses
January 2012 (Vol. 22 | No. 1 | Pages 1-16)
D. Arnone, A.M. McIntosh, K.P. Ebmeier, M.R. Munafò, I.M. Anderson
-
P.2.c.013 A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in MDD treatment
September 2011 (Vol. 21 | Page S390)
D. Baldwin, H. Loft, M. Dragheim
-
Effect of chronic mild stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and displaying different emotional behaviors
January 2011 (Vol. 21 | No. 1 | Pages 45-62)
Pawel Lisowski, Grzegorz R. Juszczak, Joanna Goscik, Marek Wieczorek, Lech Zwierzchowski, Artur H. Swiergiel
-
Corrigendum to “Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial” [Eur. Neuropsychoparmacol. 13 (2003) 267–271]
March 2004 (Vol. 14 | No. 2 | Page 173)
Kuan-Pin Su, Shih-Yi Huang, Chi-Chiang Chiu, Winston W. Shen
−/− mice and evaluation of its responses to clozapine and sarcosine treatments
